Antisense & RNAi Therapeutics Market (By Technology: RNA Interference [siRNA, miRNA], Antisense RNA; By Application: Oncology, Cardiovascular, Respiratory Disorders, Renal Diseases, Neurodegenerative Disorders, Genetic Disorders, Infectious Diseases, Other; By Route of Administration: Pulmonary Delivery, Intravenous Injections, Intradermal Injections, Intraperitoneal Injections, Topical Delivery, Other Delivery Methods) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
       1.1.1. Definition of Antisense & RNAi Therapeutics
       1.1.2. Market Segmentation
       1.1.3. List of Abbreviations
1.2. Summary
       1.2.1. Market Snapshot
       1.2.2. Antisense & RNAi Therapeutics Market By Technology
                 1.2.2.1. Global Antisense & RNAi Therapeutics Market Revenue and Growth Rate Comparison By Technology (2015-2026)
                 1.2.2.2. Global Antisense & RNAi Therapeutics Market Revenue Share By Technology in 2017
                 1.2.2.3. RNA Interference
                 1.2.2.4. Antisense RNA
                 1.2.2.5. Others
       1.2.3. Antisense & RNAi Therapeutics Market By Application
                 1.2.3.1. Global Antisense & RNAi Therapeutics Market Revenue and Growth Rate Comparison By Application (2015-2026)
                 1.2.3.2. Oncology
                 1.2.3.3. Cardiovascular
                 1.2.3.4. Respiratory Disorders
                 1.2.3.5. Renal Diseases
                 1.2.3.6. Neurodegenerative Disorders
                 1.2.3.7. Genetic Disorders
                 1.2.3.8. Infectious Diseases
                 1.2.3.9. Others
       1.2.4. Antisense & RNAi Therapeutics Market By Route of Administration
                 1.2.4.1. Global Antisense & RNAi Therapeutics Market Revenue and Growth Rate Comparison By Route of Administration (2015-2026)
                 1.2.4.2. Pulmonary Delivery
                 1.2.4.3. Intravenous Injections
                 1.2.4.4. Intradermal Injections
                 1.2.4.5. Intraperitoneal Injections
                 1.2.4.6. Topical Delivery
                 1.2.4.7. Other Delivery Methods
       1.2.5. Antisense & RNAi Therapeutics Market by Geography
                 1.2.5.1. Global Antisense & RNAi Therapeutics Market Revenue and Growth Rate Comparison by Geography (2015-2026)
                 1.2.5.2. North America Antisense & RNAi Therapeutics Market Revenue and Growth Rate (2015-2026)
                 1.2.5.3. Europe Antisense & RNAi Therapeutics Market Revenue and Growth Rate (2015-2026)
                 1.2.5.4. Asia-Pacific Antisense & RNAi Therapeutics Market Revenue and Growth Rate (2015-2026)
                 1.2.5.5. Latin America Antisense & RNAi Therapeutics Market Revenue and Growth Rate (2015-2026)
                 1.2.5.6. Middle East and Africa (MEA) Antisense & RNAi Therapeutics Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
       2.4.1. Bargaining Power of Suppliers
       2.4.2. Bargaining Power of Buyers
       2.4.3. Threat of Substitute
       2.4.4. Threat of New Entrants
       2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
       2.6.1. Raw Material and Suppliers
       2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
       2.8.1. Player Positioning Analysis
       2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Antisense & RNAi Therapeutics Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Antisense & RNAi Therapeutics Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Antisense & RNAi Therapeutics Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Antisense & RNAi Therapeutics Major Manufacturers in 2017

CHAPTER 4. ANTISENSE & RNAI THERAPEUTICS MARKET BY TECHNOLOGY

4.1. Global Antisense & RNAi Therapeutics Revenue By Technology
4.2. RNA Interference
       4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Antisense RNA
       4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Other
       4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. ANTISENSE & RNAI THERAPEUTICS MARKET BY APPLICATION

5.1. Global Antisense & RNAi Therapeutics Revenue By Application
5.2. Oncology
       5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Cardiovascular
       5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Respiratory Disorders
       5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Renal Diseases
       5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.6. Neurodegenerative Disorders
       5.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.7. Genetic Disorders
       5.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.8. Infectious Diseases
       5.8.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.8.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.9. Others
       5.9.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.9.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. ANTISENSE & RNAI THERAPEUTICS MARKET BY ROUTE OF ADMINISTRATION

6.1. Global Antisense & RNAi Therapeutics Revenue By Route of Administration
6.2. Pulmonary Delivery
       6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Intravenous Injections
       6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Intradermal Injections
       6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Intraperitoneal Injections
       6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.6. Topical Delivery
       6.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       6.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.7. Other Delivery Methods
       6.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       6.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA ANTISENSE & RNAI THERAPEUTICS MARKET BY COUNTRY

7.1. North America Antisense & RNAi Therapeutics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Antisense & RNAi Therapeutics Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
       7.3.1. U.S. Antisense & RNAi Therapeutics Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
       7.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
       7.3.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
7.4. Canada
       7.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
       7.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
       7.4.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
7.5. Mexico
       7.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
       7.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
       7.5.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE ANTISENSE & RNAI THERAPEUTICS MARKET BY COUNTRY

8.1. Europe Antisense & RNAi Therapeutics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Antisense & RNAi Therapeutics Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
       8.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
       8.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
       8.3.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
8.4. Germany
       8.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
       8.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
       8.4.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
8.5. France
       8.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
       8.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
       8.5.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
8.6. Spain
       8.6.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
       8.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
       8.6.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
8.7. Rest of Europe
       8.7.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
       8.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
       8.7.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC ANTISENSE & RNAI THERAPEUTICS MARKET BY COUNTRY

9.1. Asia-Pacific Antisense & RNAi Therapeutics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Antisense & RNAi Therapeutics Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
       9.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
       9.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
       9.3.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
9.4. Japan
       9.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
       9.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
       9.4.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
9.5. India
       9.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
       9.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
       9.5.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
9.6. Australia
       9.6.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
       9.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
       9.6.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
9.7. South Korea
       9.7.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
       9.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
       9.7.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
       9.8.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
       9.8.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
       9.8.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA ANTISENSE & RNAI THERAPEUTICS MARKET BY COUNTRY

10.1. Latin America Antisense & RNAi Therapeutics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Antisense & RNAi Therapeutics Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
         10.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
         10.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
         10.3.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
10.4. Argentina
         10.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
         10.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
         10.4.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
10.5. Rest of Latin America
         10.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
         10.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
         10.5.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST ANTISENSE & RNAI THERAPEUTICS MARKET BY COUNTRY

11.1. Middle East Antisense & RNAi Therapeutics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Antisense & RNAi Therapeutics Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Saudi Arabia
         11.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
         11.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
         11.3.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
11.4. UAE
         11.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
         11.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
         11.4.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
11.5. Rest of Middle East
         11.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
         11.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
         11.5.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)

CHAPTER 12. AFRICA ANTISENSE & RNAI THERAPEUTICS MARKET BY COUNTRY

12.1. Africa Antisense & RNAi Therapeutics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Antisense & RNAi Therapeutics Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. South Africa
         12.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
         12.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
         12.3.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
12.4. Egypt
         12.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
         12.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
         12.4.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
12.5. Rest of Africa
         12.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
         12.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
         12.5.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE

13.1. Benitec Biopharma
         13.1.1. Company Snapshot
         13.1.2. Overview
         13.1.3. Financial Overview
         13.1.4. Type Portfolio
         13.1.5. Key Developments
         13.1.6. Strategies
13.2. GSK
         13.2.1. Company Snapshot
         13.2.2. Overview
         13.2.3. Financial Overview
         13.2.4. Type Portfolio
         13.2.5. Key Developments
         13.2.6. Strategies
13.3. Alnylam Pharmaceuticals
         13.3.1. Company Snapshot
         13.3.2. Overview
         13.3.3. Financial Overview
         13.3.4. Type Portfolio
         13.3.5. Key Developments
         13.3.6. Strategies
13.4. Sanofi-Genzyme
         13.4.1. Company Snapshot
         13.4.2. Overview
         13.4.3. Financial Overview
         13.4.4. Type Portfolio
         13.4.5. Key Developments
         13.4.6. Strategies
13.5. Marina Biosciences
         13.5.1. Company Snapshot
         13.5.2. Overview
         13.5.3. Financial Overview
         13.5.4. Type Portfolio
         13.5.5. Key Developments
         13.5.6. Strategies
13.6. Others
         13.6.1. Company Snapshot
         13.6.2. Overview
         13.6.3. Financial Overview
         13.6.4. Type Portfolio
         13.6.5. Key Developments
         13.6.6. Strategies

CHAPTER 14. RESEARCH APPROACH

14.1. Research Methodology
         14.1.1. Initial Data Search
         14.1.2. Secondary Research
         14.1.3. Primary Research
14.2. Assumptions and Scope